FDA issues safety alert on breast implant-associated cancers
The Food and Drug Administration yesterday alerted health care providers and the public to reports of squamous cell carcinoma in scar tissue around breast implants, as well as lymphomas different than those previously associated with breast implants. The agency recommends that health care providers continue to report cancers around breast implants to help it identify and better understand this emerging issue.
Related News Articles
Headline
There are now 17,180 confirmed cases of cyclosporiasis in the U.S., the Centers for Disease Control and Prevention reported Aug. 25. At least 11,844 additional…
Headline
The Food and Drug Administration has approved a blood test for detecting Alzheimer’s by Roche and Eli Lilly, according to an announcement Aug. 24 by Roche. The…
Headline
There have been 15,716 confirmed cases of cyclosporiasis across 47 states, Washington, D.C., and Puerto Rico since May 1, the Centers for Disease Control and…
Blog
By Rani E. Snyder, President, The John A. Hartford Foundation and Dr. Chris DeRienzo, AHA Chief Physician Executive/President of AHA’s HRET As the U.S.…
Headline
The Department of Health and Human Services Aug. 14 announced that three health systems have signed the agency’s voluntary pledge related to hospital efforts…
Headline
The Centers for Disease Control and Prevention Aug. 11 released a health advisory on the risk of severe arboviral disease among patients receiving B-cell-…